Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kirsi Taimen
Cost-Effectiveness of Abatacept, Tocilizumab and TNF-inhibitors Compared With Rituximab as Second-Line Biologic Drug in Rheumatoid Arthritis
PLoS ONE
Multidisciplinary
Related publications
Cost Effectiveness of TNF-αInhibitors in Rheumatoid Arthritis
International Journal of Inflammation
Allergy
Immunology
Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line for the Management of Rheumatoid Arthritis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
FRI0213 Comparative Effectiveness of Abatacept, Rituximab, Tocilizumab and Anti-TNF Biological Dmards in Ra: Results From the Nationwide Swedish Register
Pms56 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Without Methotrexate in Rheumatoid Arthritis Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pms44 - Cost-Effectiveness Analysis of Subcutaneous Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Treatment
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of Abatacept Compared to Adalimumab in Italy Based on a Head-To-Head Outcomes Study in Rheumatoid Arthritis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
SAT0206 Retention of Tocilizumab as Monotherapy Versus TNF Inhibitors With Conventional Synthetic Dmards in Rheumatoid Arthritis Patients With Inadequate Response to TNF Inhibitors: A Study From the Tocerra Collaboration
Impact of TNF Inhibitors on Rheumatoid Arthritis
Inflammation and Regeneration
Allergy
Immunology
Comparative Effectiveness of Tocilizumab Versus TNF Inhibitors as Monotherapy or in Combination With Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis After the Use of at Least One Biologic Disease-Modifying Antirheumatic Drug: Analyses From the Pan-European TOCERRA Register Collaboration
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
